These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2085625)

  • 41. Probabilistic methods for addressing uncertainty and variability in biological models: application to a toxicokinetic model.
    Banks HT; Potter LK
    Math Biosci; 2004 Dec; 192(2):193-225. PubMed ID: 15627493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of cytokines by bioassays: theory and application.
    Meager A
    Methods; 2006 Apr; 38(4):237-52. PubMed ID: 16481200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case study: development of a bioassay for IL-1ra.
    Wolf J
    Dev Biol (Basel); 2002; 107():63-7. PubMed ID: 12079193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Globally multimodal problem optimization via an estimation of distribution algorithm based on unsupervised learning of Bayesian networks.
    Peña JM; Lozano JA; Larrañaga P
    Evol Comput; 2005; 13(1):43-66. PubMed ID: 15901426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of dose estimation from occupational exposure to 239Pu using different modelling approaches.
    Romanov SA; Guilmette RA; Khokhryakov VF; Phipps A; Aladova EE; Bertelli L; Birchall A; Eckerman KF; Khokhryakov VV; Krahenbuhl MP; Leggett RW; Little TT; Miller G; Miller SC; Riddell A; Suslova KG; Vostrotin VV; Zaytseva YV
    Radiat Prot Dosimetry; 2007; 127(1-4):486-90. PubMed ID: 18045798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An empirical multivariate log-normal distribution representing uncertainty of biokinetic parameters for 137Cs.
    Miller G; Melo D; Martz H; Bertelli L
    Radiat Prot Dosimetry; 2008; 131(2):198-211. PubMed ID: 18420573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Bayesian approach to bioassay.
    Ramsey FL
    Biometrics; 1972 Sep; 28(3):841-58. PubMed ID: 5073256
    [No Abstract]   [Full Text] [Related]  

  • 48. Estimating disease prevalence in a Bayesian framework using probabilistic constraints.
    Berkvens D; Speybroeck N; Praet N; Adel A; Lesaffre E
    Epidemiology; 2006 Mar; 17(2):145-53. PubMed ID: 16477254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Bayesian approach for the evaluation of six diagnostic assays and the estimation of Cryptosporidium prevalence in dairy calves.
    Geurden T; Berkvens D; Geldhof P; Vercruysse J; Claerebout E
    Vet Res; 2006; 37(5):671-82. PubMed ID: 16777038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analyzing bioassay data using Bayesian methods--a primer.
    Miller G; Inkret WC; Schillaci ME; Martz HF; Little TT
    Health Phys; 2000 Jun; 78(6):598-613. PubMed ID: 10832919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of lattice square designs in bioassays.
    Wang W; Kshirsagar AM
    J Biopharm Stat; 1996 May; 6(2):185-99. PubMed ID: 8732913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the statistical analysis of bioassays.
    Wong MY
    Comput Methods Programs Biomed; 1996 May; 49(3):191-7. PubMed ID: 8800606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new parallelism acceptance criterion for validating large plate bioassay results.
    Story MJ; Winson JA; Beyer PL; Boehm G
    J Biol Stand; 1986 Jul; 14(3):249-54. PubMed ID: 3759999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addressing Unusual Assay Variability with Robust Statistics.
    Haelewyn J; Iversen PW; Weidner JR
    SLAS Discov; 2021 Dec; 26(10):1291-1297. PubMed ID: 34474612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statistical issues in assay development and use.
    Giltinan D
    Adv Exp Med Biol; 1998; 445():173-90. PubMed ID: 9781389
    [No Abstract]   [Full Text] [Related]  

  • 56. Setting course for a translational pharmacology and a predictive toxicology based on the numerical probability of clinical relevance.
    Suarez-Torres JD; Ciangherotti CE; Orozco CA
    Environ Toxicol Pharmacol; 2023 Jan; 97():103968. PubMed ID: 36075507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The arithmetic mean of ratio-normalized experiments overestimates the true E/C ratio.
    Engström S; Lindgren M
    Bioelectromagnetics; 2000 Feb; 21(2):137-44. PubMed ID: 10653625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. METHOD OF GRAPHICAL ANALYSIS OF 2+2 AND 3+3 BIOLOGICAL ASSAYS WITH GRADED RESPONSES.
    WARNER BT
    J Pharm Pharmacol; 1964 Apr; 16():220-33. PubMed ID: 14176340
    [No Abstract]   [Full Text] [Related]  

  • 59. Estimating radioelements in exposed individuals--III bioassay operations and procedures.
    SCHUBERT J
    Nucleonics; 1951 Apr; 8(4):59-67. PubMed ID: 14833573
    [No Abstract]   [Full Text] [Related]  

  • 60. A Bayesian analysis of the slope ratio bioassay.
    Mendoza M
    Biometrics; 1990 Dec; 46(4):1059-69. PubMed ID: 2085625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.